Copying the image from chillier's post with the fibronectin levels:
From
Normal fibronectin levels as a function of age in the pediatric population
So, 220 ug/ml is a normal serum level for adults. From the charts, it is possible that there is a subset of people with ME/CFS and post-Covid fatiguing illness with higher fibronectin levels, although the mean for the healthy controls is perhaps lower than normal. Maybe the test was slightly different.
The chart separating out the levels by illness severity is quite interesting.
From
Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity
from
Plasma Fibronectin Concentration A Risk Factor for Arterial Thrombosis?
So, I think it is possible that serum fibronectin levels might tend to be higher in people with ME/CFS and ME/CFS-like Long Covid. Whether that tells us anything useful about the underlying pathology, I don't know.
I'll be looking hard at the demographic information given for the samples in Prusty's paper, to see if there were differences in BMI, age and co-morbidities. And also looking for some very convincing support for his contention that fibronectin serum levels are higher in healthy women than healthy men, as my preliminary googling didn't support that.
From
Normal fibronectin levels as a function of age in the pediatric population
Normal adult serum fibronectin concentrations are typically 220 micrograms/ml +/- 20 micrograms/ml. Serum concentration is 35-40% lower than normal plasma concentration due to the binding of fibronectin to fibrin during clot formation.
So, 220 ug/ml is a normal serum level for adults. From the charts, it is possible that there is a subset of people with ME/CFS and post-Covid fatiguing illness with higher fibronectin levels, although the mean for the healthy controls is perhaps lower than normal. Maybe the test was slightly different.
The chart separating out the levels by illness severity is quite interesting.
From
Plasma fibronectin in overweight men and women: correlation with serum triglyceride levels and serum cholinesterase activity
That paper (note it is talking about plasma not serum) does not seem to support the presence of the sex difference that Prusty is reported to have mentioned. Furthermore, it suggests that there might be a link between obesity and fibronectin levels. In that case, it perhaps would not be surprising that a higher percentage of people with a disease that limits activity would be obese, and would therefore show higher levels of a molecule associated with obesity.When compared with 67 age- and sex-matched normal weight control subjects, the 71 overweight patients displayed obviously higher levels of plasma fibronectin. For a similar body mass index (BMI) the 16 overweight men younger than 45 years had a significantly (P < 0.01) higher plasma fibronectin level (455 +/- 99.3 mg/l; mean +/- SD) than the 16 age-matched overweight women (351 +/- 105 mg/l) while there was no significant difference between the 22 overweight men (446 +/- 89.2 mg/l) and the 17 overweight women (475 +/- 111 mg/l) older than 45 years. Particularly high plasma fibronectin levels were noted in the five women with upper body (android) obesity. Plasma fibronectin was positively correlated with BMI, serum triglyceride concentration, plasma fibrinogen and serum cholinesterase activity. It is considered that metabolic disturbances related to upper body obesity may lead to an enhanced hepatic secretion of VLDL and of several plasma proteins including fibronectin.
from
Plasma Fibronectin Concentration A Risk Factor for Arterial Thrombosis?
So, that paper also is not supporting the idea of higher levels of fibronectin in the serum of healthy women (vs healthy men).There is a considerable range in fibronectin concentrations in the adult population, with a tendency for the concentration to be higher in men than in women, increase with age, and increase in the presence of malignancy or inflammation
So, I think it is possible that serum fibronectin levels might tend to be higher in people with ME/CFS and ME/CFS-like Long Covid. Whether that tells us anything useful about the underlying pathology, I don't know.
I'll be looking hard at the demographic information given for the samples in Prusty's paper, to see if there were differences in BMI, age and co-morbidities. And also looking for some very convincing support for his contention that fibronectin serum levels are higher in healthy women than healthy men, as my preliminary googling didn't support that.